
NuVasive NUVA
Quartalsbericht 2023-Q2
hinzugefügt 02.08.2023
NuVasive Langfristige Verbindlichkeiten 2011-2026 | NUVA
Langfristige Verbindlichkeiten Jährlich NuVasive
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 763 M | 694 M | 679 M | 628 M | 488 M | 480 M | 458 M | 462 M | 411 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 763 M | 411 M | 563 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
EDAP TMS S.A.
EDAP
|
7.44 M | $ 4.13 | -0.72 % | $ 155 M | ||
|
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.67 | 3.09 % | $ 151 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | ||
|
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | ||
|
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
89.9 M | $ 7.52 | -2.97 % | $ 1.13 B | ||
|
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | ||
|
Helius Medical Technologies
HSDT
|
252 K | $ 2.22 | 3.26 % | $ 1.35 M | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | ||
|
OrthoPediatrics Corp.
KIDS
|
116 M | $ 17.81 | 1.37 % | $ 418 M | ||
|
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | ||
|
LENSAR
LNSR
|
3.44 M | $ 5.64 | 7.84 % | $ 67.4 M | ||
|
ClearPoint Neuro
CLPT
|
23.9 M | $ 12.82 | 9.76 % | $ 363 M | ||
|
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | ||
|
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | ||
|
Cytosorbents Corporation
CTSO
|
14 M | $ 0.61 | -0.08 % | $ 38 M | ||
|
LivaNova PLC
LIVN
|
516 M | $ 71.86 | 1.32 % | $ 3.92 B | ||
|
Delcath Systems
DCTH
|
2.52 M | $ 11.48 | 2.14 % | $ 411 M | ||
|
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | ||
|
Orthofix Medical
OFIX
|
83.1 M | $ 11.65 | -3.48 % | $ 461 M | ||
|
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | ||
|
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.03 | - | $ 17.4 M | ||
|
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
161 M | - | - | $ 10.2 M | ||
|
Myomo
MYO
|
275 K | $ 0.83 | -5.05 % | $ 34.7 M | ||
|
Electromed
ELMD
|
8.87 K | $ 26.93 | 0.26 % | $ 228 M | ||
|
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | ||
|
Profound Medical Corp.
PROF
|
2.44 M | $ 6.85 | -4.33 % | $ 207 M | ||
|
Insulet Corporation
PODD
|
1.06 B | $ 154.16 | -3.89 % | $ 10.8 B | ||
|
Sintx Technologies
SINT
|
1.76 M | $ 2.35 | -2.08 % | $ 6.52 M | ||
|
Globus Medical
GMED
|
18.2 M | $ 77.95 | -8.37 % | $ 10.5 B | ||
|
CONMED Corporation
CNMD
|
877 M | $ 36.76 | -3.52 % | $ 1.14 B | ||
|
Stryker Corporation
SYK
|
13 B | $ 285.47 | -2.98 % | $ 109 B | ||
|
Inspire Medical Systems
INSP
|
24.6 M | $ 44.26 | -2.87 % | $ 1.3 B | ||
|
Integer Holdings Corporation
ITGR
|
1.02 B | $ 88.12 | 0.23 % | $ 3.06 B | ||
|
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.44 B | $ 79.96 | -3.44 % | $ 46.8 B | ||
|
Tandem Diabetes Care
TNDM
|
31.7 M | $ 15.48 | -16.19 % | $ 1.05 B |